Pulmonary hypertension in patients with bronchiolitis obliterans syndrome listed for retransplantation

S. D. Nathan, O. A. Shlobin, S. Ahmad, S. D. Barnett, N. A. Burton, M. T. Gladwin, Roberto Machado

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Bronchiolitis Obliterans Syndrome (BOS) is a major cause of morbidity and mortality post-lung transplantation. Pulmonary hypertension (PH) may complicate the course of patients with advanced lung disease. We sought to characterize the prevalence of PH in patients with BOS. We performed a retrospective analysis of lung transplant recipients with BOS relisted for transplantation with the United Network for Organ Sharing (UNOS). Right heart catheterization (RHC) data were required for analysis. Eighty patients with BOS qualified for the analysis. PH was present in 32.5% of patients with an average mean pulmonary artery pressure (mPAP) of 32.3 mmHg (range: 26-63 mmHg). Of these, 42.3% had an elevated pulmonary capillary wedge pressure. There was no difference in PH prevalence between bilateral (26.5%) and single lung recipients (41.9%), nor did it differ by primary disease. There was no correlation between pulmonary function data and the presence or severity of PH. There was no difference in oxygen requirements or 6-min walk distance between patients with and without PH. This is the first report of PH in patients with BOS. Many of these cases occur in association with diastolic dysfunction. Although no impact on functional status or outcomes was discerned, further studies appear warranted.

Original languageEnglish (US)
Pages (from-to)1506-1511
Number of pages6
JournalAmerican Journal of Transplantation
Volume8
Issue number7
DOIs
StatePublished - Jul 1 2008
Externally publishedYes

Fingerprint

Bronchiolitis Obliterans
Pulmonary Hypertension
Lung
Pulmonary Wedge Pressure
Lung Transplantation
Cardiac Catheterization
Pulmonary Artery
Lung Diseases
Transplantation
Oxygen
Morbidity
Pressure
Mortality

Keywords

  • Bronchiolitis obliterans
  • Chronic rejection
  • Hypertension
  • Lung transplantation
  • Pulmonary

ASJC Scopus subject areas

  • Immunology

Cite this

Pulmonary hypertension in patients with bronchiolitis obliterans syndrome listed for retransplantation. / Nathan, S. D.; Shlobin, O. A.; Ahmad, S.; Barnett, S. D.; Burton, N. A.; Gladwin, M. T.; Machado, Roberto.

In: American Journal of Transplantation, Vol. 8, No. 7, 01.07.2008, p. 1506-1511.

Research output: Contribution to journalArticle

Nathan, S. D. ; Shlobin, O. A. ; Ahmad, S. ; Barnett, S. D. ; Burton, N. A. ; Gladwin, M. T. ; Machado, Roberto. / Pulmonary hypertension in patients with bronchiolitis obliterans syndrome listed for retransplantation. In: American Journal of Transplantation. 2008 ; Vol. 8, No. 7. pp. 1506-1511.
@article{30d7baf35d0f4611bd326ae3f5f8cace,
title = "Pulmonary hypertension in patients with bronchiolitis obliterans syndrome listed for retransplantation",
abstract = "Bronchiolitis Obliterans Syndrome (BOS) is a major cause of morbidity and mortality post-lung transplantation. Pulmonary hypertension (PH) may complicate the course of patients with advanced lung disease. We sought to characterize the prevalence of PH in patients with BOS. We performed a retrospective analysis of lung transplant recipients with BOS relisted for transplantation with the United Network for Organ Sharing (UNOS). Right heart catheterization (RHC) data were required for analysis. Eighty patients with BOS qualified for the analysis. PH was present in 32.5{\%} of patients with an average mean pulmonary artery pressure (mPAP) of 32.3 mmHg (range: 26-63 mmHg). Of these, 42.3{\%} had an elevated pulmonary capillary wedge pressure. There was no difference in PH prevalence between bilateral (26.5{\%}) and single lung recipients (41.9{\%}), nor did it differ by primary disease. There was no correlation between pulmonary function data and the presence or severity of PH. There was no difference in oxygen requirements or 6-min walk distance between patients with and without PH. This is the first report of PH in patients with BOS. Many of these cases occur in association with diastolic dysfunction. Although no impact on functional status or outcomes was discerned, further studies appear warranted.",
keywords = "Bronchiolitis obliterans, Chronic rejection, Hypertension, Lung transplantation, Pulmonary",
author = "Nathan, {S. D.} and Shlobin, {O. A.} and S. Ahmad and Barnett, {S. D.} and Burton, {N. A.} and Gladwin, {M. T.} and Roberto Machado",
year = "2008",
month = "7",
day = "1",
doi = "10.1111/j.1600-6143.2008.02277.x",
language = "English (US)",
volume = "8",
pages = "1506--1511",
journal = "American Journal of Transplantation",
issn = "1600-6135",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - Pulmonary hypertension in patients with bronchiolitis obliterans syndrome listed for retransplantation

AU - Nathan, S. D.

AU - Shlobin, O. A.

AU - Ahmad, S.

AU - Barnett, S. D.

AU - Burton, N. A.

AU - Gladwin, M. T.

AU - Machado, Roberto

PY - 2008/7/1

Y1 - 2008/7/1

N2 - Bronchiolitis Obliterans Syndrome (BOS) is a major cause of morbidity and mortality post-lung transplantation. Pulmonary hypertension (PH) may complicate the course of patients with advanced lung disease. We sought to characterize the prevalence of PH in patients with BOS. We performed a retrospective analysis of lung transplant recipients with BOS relisted for transplantation with the United Network for Organ Sharing (UNOS). Right heart catheterization (RHC) data were required for analysis. Eighty patients with BOS qualified for the analysis. PH was present in 32.5% of patients with an average mean pulmonary artery pressure (mPAP) of 32.3 mmHg (range: 26-63 mmHg). Of these, 42.3% had an elevated pulmonary capillary wedge pressure. There was no difference in PH prevalence between bilateral (26.5%) and single lung recipients (41.9%), nor did it differ by primary disease. There was no correlation between pulmonary function data and the presence or severity of PH. There was no difference in oxygen requirements or 6-min walk distance between patients with and without PH. This is the first report of PH in patients with BOS. Many of these cases occur in association with diastolic dysfunction. Although no impact on functional status or outcomes was discerned, further studies appear warranted.

AB - Bronchiolitis Obliterans Syndrome (BOS) is a major cause of morbidity and mortality post-lung transplantation. Pulmonary hypertension (PH) may complicate the course of patients with advanced lung disease. We sought to characterize the prevalence of PH in patients with BOS. We performed a retrospective analysis of lung transplant recipients with BOS relisted for transplantation with the United Network for Organ Sharing (UNOS). Right heart catheterization (RHC) data were required for analysis. Eighty patients with BOS qualified for the analysis. PH was present in 32.5% of patients with an average mean pulmonary artery pressure (mPAP) of 32.3 mmHg (range: 26-63 mmHg). Of these, 42.3% had an elevated pulmonary capillary wedge pressure. There was no difference in PH prevalence between bilateral (26.5%) and single lung recipients (41.9%), nor did it differ by primary disease. There was no correlation between pulmonary function data and the presence or severity of PH. There was no difference in oxygen requirements or 6-min walk distance between patients with and without PH. This is the first report of PH in patients with BOS. Many of these cases occur in association with diastolic dysfunction. Although no impact on functional status or outcomes was discerned, further studies appear warranted.

KW - Bronchiolitis obliterans

KW - Chronic rejection

KW - Hypertension

KW - Lung transplantation

KW - Pulmonary

UR - http://www.scopus.com/inward/record.url?scp=47249092307&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47249092307&partnerID=8YFLogxK

U2 - 10.1111/j.1600-6143.2008.02277.x

DO - 10.1111/j.1600-6143.2008.02277.x

M3 - Article

C2 - 18510629

AN - SCOPUS:47249092307

VL - 8

SP - 1506

EP - 1511

JO - American Journal of Transplantation

JF - American Journal of Transplantation

SN - 1600-6135

IS - 7

ER -